DE60324418D1 - Nicht-nukleosidische inhibitoren der reversen transkriptase - Google Patents

Nicht-nukleosidische inhibitoren der reversen transkriptase

Info

Publication number
DE60324418D1
DE60324418D1 DE60324418T DE60324418T DE60324418D1 DE 60324418 D1 DE60324418 D1 DE 60324418D1 DE 60324418 T DE60324418 T DE 60324418T DE 60324418 T DE60324418 T DE 60324418T DE 60324418 D1 DE60324418 D1 DE 60324418D1
Authority
DE
Germany
Prior art keywords
reverse transcriptase
nucleoside inhibitors
nucleoside
inhibitors
transcriptase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324418T
Other languages
English (en)
Inventor
Bruno Simoneau
Serge Landry
Eric Malenfant
Julie Naud
Jeffrey O'meara
Bounkham Thavonekham
Christiane Yoakim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of DE60324418D1 publication Critical patent/DE60324418D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60324418T 2002-05-16 2003-05-14 Nicht-nukleosidische inhibitoren der reversen transkriptase Expired - Lifetime DE60324418D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
DE60324418D1 true DE60324418D1 (de) 2008-12-11

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324418T Expired - Lifetime DE60324418D1 (de) 2002-05-16 2003-05-14 Nicht-nukleosidische inhibitoren der reversen transkriptase

Country Status (29)

Country Link
US (1) US6806265B2 (de)
EP (1) EP1506195B1 (de)
JP (1) JP4230448B2 (de)
KR (1) KR20050008716A (de)
CN (1) CN1318421C (de)
AR (1) AR040027A1 (de)
AT (1) ATE412653T1 (de)
AU (1) AU2003229186A1 (de)
BR (1) BR0310033A (de)
CA (1) CA2485916C (de)
DE (1) DE60324418D1 (de)
EA (1) EA009178B1 (de)
EC (1) ECSP045432A (de)
ES (1) ES2315492T3 (de)
HK (1) HK1080849A1 (de)
HR (1) HRP20041065A2 (de)
IL (1) IL163753A0 (de)
MX (1) MXPA04010409A (de)
MY (1) MY134646A (de)
NO (1) NO20044104L (de)
NZ (1) NZ536736A (de)
PE (1) PE20040365A1 (de)
PL (1) PL371663A1 (de)
RS (1) RS98004A (de)
TW (1) TW200404071A (de)
UA (1) UA79285C2 (de)
UY (1) UY27809A1 (de)
WO (1) WO2003097644A2 (de)
ZA (1) ZA200406912B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
NZ545326A (en) * 2003-07-17 2009-12-24 Plexxikon Inc PPAR active compounds
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン,インコーポレーテッド Ppar活性化合物
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン,インコーポレーテッド Ppar活性化合物
AU2006287521A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. PPARactive compounds
US20070072904A1 (en) * 2005-09-07 2007-03-29 Jack Lin PPAR active compounds
WO2008051197A2 (en) 2005-09-20 2008-05-02 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
US10047096B2 (en) 2014-11-25 2018-08-14 Bayer Pharma Aktiengesellschaft Substituted pyridobenzodiazepinone-derivatives and use thereof
KR20200030584A (ko) 2017-07-21 2020-03-20 앤타바이오 에스에이에스 화합물
SI3762368T1 (sl) 2018-03-08 2022-06-30 Incyte Corporation Aminopirazin diolne spojine kot zaviralci PI3K-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
IL163753A0 (en) 2005-12-18
NO20044104L (no) 2004-12-01
PL371663A1 (en) 2005-06-27
CA2485916A1 (en) 2003-11-27
RS98004A (en) 2006-12-15
UY27809A1 (es) 2003-12-31
KR20050008716A (ko) 2005-01-21
ES2315492T3 (es) 2009-04-01
ZA200406912B (en) 2006-06-28
US20040006071A1 (en) 2004-01-08
MY134646A (en) 2007-12-31
EP1506195B1 (de) 2008-10-29
WO2003097644A3 (en) 2004-02-05
HK1080849A1 (en) 2006-05-04
US6806265B2 (en) 2004-10-19
CN1653066A (zh) 2005-08-10
AU2003229186A1 (en) 2003-12-02
NZ536736A (en) 2006-11-30
BR0310033A (pt) 2005-02-15
ECSP045432A (es) 2005-01-03
PE20040365A1 (es) 2004-07-22
JP2005526851A (ja) 2005-09-08
AR040027A1 (es) 2005-03-09
ATE412653T1 (de) 2008-11-15
JP4230448B2 (ja) 2009-02-25
EP1506195A2 (de) 2005-02-16
TW200404071A (en) 2004-03-16
WO2003097644A2 (en) 2003-11-27
MXPA04010409A (es) 2005-02-17
CN1318421C (zh) 2007-05-30
UA79285C2 (en) 2007-06-11
EA200401482A1 (ru) 2005-06-30
HRP20041065A2 (en) 2005-04-30
CA2485916C (en) 2009-12-08
EA009178B1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
DE602004008227D1 (de) Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase
DE602005017604D1 (de) Inhibitoren der nicht-nukleosid-inhibitoren der reversen transkriptase
NO20054264D0 (no) Ikke-Nukleoside Revers Transkriptase-Inhibitorer I for behandling av HIV-medierte sydommer
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
DK1562589T3 (da) Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser
DK1534290T3 (da) Hidtil ukendte kinasehæmmere
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
HK1111155A1 (en) Non-nucleoside reverse transcriptase inhibitors
ATE322492T1 (de) Nicht-nukleosid reverse transkriptase inhibitoren
DE60324250D1 (de) Inhibitoren der alpha-l-beta-2-integrinvermittelten zelladhäsion
NO20043610L (no) Fenylpyrimidinaminer som IgE inhibitorer
DE60235470D1 (de) N-heterocyclische inhibitoren der expression von tnf-alpha
DE60226903D1 (de) Verzögerungsinterferometer
DE60326035D1 (de) Dipyridodiazepinone als inhibitoren der reversen transkriptase
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
SE0203540D0 (sv) Use of an inhibilor or antagonist against lissue factor
ITVA20020048A1 (it) Procedimento per la realizzazione di componenti di

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, 552, DE

8364 No opposition during term of opposition